|
pubmed:abstractText |
The optimal antithrombotic treatment for patients on long-term anticoagulation undergoing invasive coronary procedures is currently undefined. The strategies adopted periprocedurally and medium-term after coronary stenting (percutaneous coronary intervention with stent implantation) at our Institution, were reviewed, and the safety and efficacy of the various regimens evaluated.
|
|
pubmed:affiliation |
Division of Cardiology, Maggiore Hospital, Bologna, Italy, and School of Medicine, Karolinska University, Stockholm, Sweden. andrearubboli@libero.it
|
